Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 800.00 | 51.70K | 2.20K | 51.10K | 1.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 800.00 | 51.70K | 2.20K | 51.10K | 1.10K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 800.00 | 51.70K | 2.20K | 51.10K | 1.10K |
| SG&A Expenses | 1.21M | 1.10M | 894.90K | 1.39M | 894.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93M | 2.77M | 2.62M | 2.76M | 3.16M |
| Operating Income | -2.93M | -2.72M | -2.61M | -2.71M | -3.16M |
| Income Before Tax | -2.87M | -3.05M | -2.48M | -2.56M | -4.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.87M | -3.05M | -2.48M | -2.56M | -4.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.87M | -3.05M | -2.48M | -2.56M | -4.37M |
| EBIT | -2.93M | -2.72M | -2.61M | -2.71M | -3.16M |
| EBITDA | -2.93M | -2.72M | -2.61M | -2.71M | -3.15M |
| EPS Basic | -1.96 | -2.03 | -1.81 | -1.85 | -2.31 |
| Normalized Basic EPS | -0.69 | -0.64 | -0.60 | -0.62 | -1.06 |
| EPS Diluted | -1.96 | -2.03 | -1.81 | -1.85 | -2.31 |
| Normalized Diluted EPS | -0.69 | -0.64 | -0.60 | -0.62 | -1.06 |
| Average Basic Shares Outstanding | 2.59M | 2.59M | 2.59M | 2.59M | 2.59M |
| Average Diluted Shares Outstanding | 2.59M | 2.59M | 2.59M | 2.59M | 2.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
